Navigation Links
US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
Date:8/16/2009

the US. Betaseron and Betaferon are registered trademarks of Bayer Schering Pharma AG.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "planned," "may," "committed," "long-term commitment," "will," "can," "likely," or similar expressions, or by express or implied discussions regarding potential future multiple sclerosis products or regarding potential future revenues from Extavia or other multiple sclerosis products. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that any additional Novartis multiple sclerosis products will be approved for sale in any market. Nor can there be any guarantee that Extavia or such other products will achieve any particular levels of revenue in the future. In particular, management's expectations regarding such products could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; competition in general; government, industry and general public pricing pressures; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of t
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
2. FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
3. FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
4. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
5. FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
6. FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
7. FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
8. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
9. FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
10. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
11. F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ –  ... PHG AEX: PHIA) today announced ... Society of Cardiology (ESC) Congress 2014 ... range of its cardiology solutions serving clinicians and ... prevention and diagnosis, to treatment, ...
(Date:8/28/2014)... 2014 Reportlinker.com announces that a new ... North America Aesthetic Lasers and Energy ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North America Aesthetic ... Summary GlobalData,s new report, "North America ... 2020", provides key market data on the North ...
(Date:8/28/2014)... Del. , Aug. 28, 2014  Rigrodsky & Long, P.A.: ... of Lannett Company, Inc. (NYSE: LCI )? , ... September 10, 2013 and July 16, 2014, inclusive? , ... , Do you want to discuss your rights? ... Special Assistant United States Attorney, Timothy J. MacFall , announces ...
Breaking Medicine Technology:Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3
... Jan. 25 Richard Cooper Woodyard , Vice ... January 19th after a 2-year fight with cancer. ... eCardio as Vice President, Business Development. As Vice President, Sales, ... responsible for identifying, negotiating and integrating new partners, products, technologies, ...
... , SOUTH SAN FRANCISCO, Calif. , ... announced today that Institutional Shareholder Services/Risk Metrics Group (ISS) and ... advisory firms, recommend that VaxGen stockholders vote "FOR" the proposed ... Proposal to adjourn the VaxGen special meeting, if necessary, to ...
Cached Medicine Technology:Richard Woodyard, Vice President of Sales at eCardio, Loses Fight Against Cancer 2ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 2ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 3ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 4ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE 5
(Date:8/29/2014)... August 29, 2014 Innovations Television, produced by ... upcoming episodes of Innovations, focusing on health and elderly care, ... show the number of Americans over 65 will nearly double ... to 20% in 2030, for a total of 72 million ... health, most have at least one chronic condition and use ...
(Date:8/29/2014)... TX (PRWEB) August 29, 2014 Many ... and to keep diabetes type 2 at bay, patients ... time to make the necessary lifestyle changes. While some ... as family history, advanced age, or belonging to certain ... can control – their weight. Carrying extra pounds, especially ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Fat is fat, ... bad fat. Brown fat is usually stored in the upper ... fat typically reveals itself in overflowing bellies, muffin tops, love ... occur naturally in many foods and promote better health, trans ... including elevated bad cholesterol levels and lower good cholesterol levels, ...
(Date:8/29/2014)... Gwyneth Paltrow, Beyonce and Angelina Jolie are only ... dieters all over the United States, to find the best ... them quickly shed excess fat. And, recent inspiration has come ... all gluten products, eggs and meats for ingredients like goji ... following this type of diet, one must be a celebrity ...
(Date:8/29/2014)... Scientists from four European countries say they have ... overall survival of mesothelioma. Surviving Mesothelioma has just posted ... to read it now. , Doctors from France, ... 523 mesothelioma patients who were part of ... at 18 weeks after treatment] was strongly correlated and ...
Breaking Medicine News(10 mins):Health News:Innovations with Ed Begley, Jr., Seeking Content for Upcoming Series on Health and Elder Care 2Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 2Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 3Health News:Diet Doc Announces Modernized, Interesting and Easy to Follow Diet Plans that Deliver Fast Weight Loss and Teach Patients the Difference Between Good and Bad Fat 2Health News:Diet Doc Announces Modernized, Interesting and Easy to Follow Diet Plans that Deliver Fast Weight Loss and Teach Patients the Difference Between Good and Bad Fat 3Health News:Diet Doc Announces Diet Plans that Deliver Fast Weight Loss Results at a Fraction of the Cost of Celebrity Diets 2Health News:Diet Doc Announces Diet Plans that Deliver Fast Weight Loss Results at a Fraction of the Cost of Celebrity Diets 3Health News:European Study Says Disease Progression Predicts Mesothelioma Survival Better Than Treatment Response, According to Surviving Mesothelioma 2
... for May 12, 2008 at 1:30 p.m. (Pacific); ... webcast at http://www.adventrx.com , SAN DIEGO, May 5 ... it will host a conference call with,simultaneous webcast to discuss ... p.m. Pacific / 4:30 p.m. Eastern. Evan M. Levine, Chief,Executive ...
... Veterinary Medical,Association (AVMA) reiterated today, at the start ... veterinarians working in the,public sector and urged Congress ... Veterinarians fill essential positions at agencies, including ... of Agriculture,the US Food and Drug Administration and ...
... Mich.---A new study suggests that extra iron for infants who ... the debate over optimal iron supplement levels and could have ... "Our results for 25 years of research show problems with ... a big deal, it,s really unexpected," said Dr. Betsy Lozoff, ...
... LATEST REVIEW SUGGESTS LABAs ARE SAFE AND EFFECTIVE FOR ... of long-acting β2-agonists (LABA) to increased risk for adverse ... to severe chronic obstructive pulmonary disease (COPD); however, a ... In a new metaanalysis, researchers from Spain, Argentina, and ...
... York, NY A preliminary analysis of ongoing research suggests that ... BRCA1/2 mutation may face a greater chance for developing a ... risk of cancer in these women, should sentinel node biopsy ... can women best be counseled after these findings? , ...
... help bridge this knowledge gap, experts say , , SUNDAY, ... babies have a surprisingly low knowledge of child development, ... or how they should act, a new study finds. ... don,t know that 1-year-olds can,t tell the difference between ...
Cached Medicine News:Health News:AVMA Recognizes Public Veterinarians Urges Congressional Action 2Health News:Iron supplements might harm infants who have enough 2Health News:News briefs: May issue of the journal Chest 2Health News:Second breast cancer may be greater than thought for high-risk women without BRCA mutations 2Health News:One-Third of Parents Lack Facts About Child Development 2Health News:One-Third of Parents Lack Facts About Child Development 3
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
... medication as well as humidification, try Flo-Mist™., ... high volume, continuous medication nebulizer (CMN), engineered ... Its 200 ml reservoir and jet flow ... of nebulized medication delivery at 25 ml/hr. ...
Infant Nebulizer Kit W/Misty-Nebulizer 30/CS CE Mark Only...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
Medicine Products: